Author Archive: Tracy Cooley

Tracy was the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues.

Latest Posts

NORD Urges Congress: Don’t Cut Orphan Drug Tax Credit


This week, the National Organization of Rare Disorders (NORD) and more than 70 patient organizations sent a letter to key members of Congress in support of maintaining the Orphan Drug Tax Credit. Representing millions of American men, women and children suffering from rare diseases, the organizations voice strong support for the Orphan Drug Tax Credit (ODTC) and urge Congress to keep this critical tax credit in place as tax reform proposals are developed. According to Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Biodefense Preparedness Key for National Public Health


Over the last decade, our nation has responded to deliberate biological attacks – the mailing of anthrax-laden letters – and severe naturally-occurring disease outbreaks including SARS and the 2009-H1N1 flu pandemic. As an industry, biotechnology can help improve our nation’s capacity to prepare and respond to natural disasters, bioterrorist attacks, and outbreaks of infectious disease. The Biomedical Advanced Research and Development Authority (BARDA) was established to support the advanced development and procurement of drugs, vaccines, Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Hill: Innovation-focused tax reform for U.S. global competitiveness

DC in Fall

The Hill Blog published an op-ed by Geoff Davis on ‘Innovation-focused tax reform for U.S. global competitiveness.’ Davis, a former member of the House Ways & Means Committee, which has responsibility for writing our nation’s tax laws,  urges policymakers to support innovative, research-intensive businesses by encouraging private investment as they move towards tax reform. As he states, “If the U.S. is to remain competitive in the global economy, we need to make sure there are policies Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

Ellmers’ Cancer Bill Marks 100 Co-Sponsors


Today, Congresswoman Ellmers announced that 100 bipartisan cosponsors have signed on to support her bill – The Cancer Patients Protection Act of 2013 (H.R. 1416). The bill aims to ‘protect cancer patients from the harmful effects of the misallocated sequestration cuts.’  The bill also protects patients suffering from other diseases too.  In a statement from the Congresswoman, she points out that the focus of sequestration is to reduce spending, but treating patients in hospitals is Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Separating Science from Fiction

The Atlantic recently published a story on the dangers of anti-vaccine rhetoric, “Destabilizing the Jenny McCarthy Public-Health Industrial Complex.” The article describes the hysteria around the alleged link between autism and vaccines, which has since been scientifically discredited. The public campaign created fear among parents, some of whom chose not to vaccinate their children. As the author states, “Anti-vaccinators risk not only the lives of their own children, but also those of others who are Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,